Latest On Novozymes A/S (NVZMY):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-10-20 05:58 EST | Dividend | A dividend of $0.59 has been announced on Oct 12, 2023. It will be paid Nov 1, 2023 with an ex-dividend date of Oct 20, 2023. | Neutral |  |
| 2023-04-27 00:35 EST | News | Novozymes A/S (NVZMF) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-04-26 12:29 EST | News | Novozymes A/S GAAP EPS of DKK2.82, revenue of DKK4.62B; reaffirms FY22 guidance | N/A | |
| 2023-03-21 13:28 EST | News | Novozymes: Macro Risks Must Be Weighed Against Valuation | N/A | |
| 2023-03-06 04:58 EST | Dividend | A dividend of $0.88 has been announced on Jan 30, 2023. It will be paid Mar 23, 2023 with an ex-dividend date of Mar 6, 2023. | Neutral | |
| 2023-03-03 04:59 EST | Dividend | A dividend of $0.88 has been announced on Jan 30, 2023. It will be paid Mar 22, 2023 with an ex-dividend date of Mar 3, 2023. | Neutral | |
| 2023-01-27 03:28 EST | News | Novozymes A/S 2022 Q4 - Results - Earnings Call Presentation | N/A | |
| 2023-01-27 03:28 EST | News | Novozymes A/S (NVZMF) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-01-23 22:01 EST | News | Novozymes: Wonderful Company, Almost Reasonable Price | N/A | |
| 2022-11-05 05:12 EST | News | Novozymes A/S 2022 Q3 - Results - Earnings Call Presentation | N/A | |
| 2022-11-05 05:12 EST | News | Novozymes A/S (NVZMF) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-03 19:34 EST | News | Novozymes A/S reports Q3 results; raises its full-year organic sales growth outlook | N/A | |
| 2022-08-13 04:37 EST | News | Novozymes A/S 2022 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-08-11 19:33 EST | News | Novozymes A/S reports 1H results | N/A | |
| 2022-08-11 19:33 EST | News | Novozymes A/S (NVZMF) CEO Ester Baiget on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-04-27 15:19 EST | News | Novozymes A/S (NVZMF) CEO Ester Baiget on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-03-17 05:59 EST | Dividend | A dividend of $0.85 has been announced on Feb 4, 2022. It will be paid Apr 5, 2022 with an ex-dividend date of Mar 17, 2022. | Neutral | |
| 2022-02-23 09:33 EST | News | Warning: NVZMY is at high risk of cutting their dividend | N/A | |
| 2022-02-01 19:36 EST | News | Novozymes A/S GAAP EPS of DKK11.23, revenue of DKK14.95B | N/A | |
| 2022-02-01 19:36 EST | News | Novozymes A/S 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-02-01 19:36 EST | News | Novozymes A/S (NVZMF) CEO Ester Baiget On Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2021-12-13 11:39 EST | News | Novozymes, Saipem collaborate to create a more sustainable CO2 capture | N/A | |
| 2021-10-28 08:00 EST | News | Novozymes A/S (NVZMF) CEO Ester Baiget on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-10-28 08:00 EST | News | Novozymes A/S 2021 Q3 - Results - Earnings Call Presentation | N/A | |
| 2021-08-13 05:03 EST | News | Novozymes A/S 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-08-13 05:02 EST | News | Novozymes A/S (NVZMF) CEO Ester Baiget on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-07-22 12:48 EST | News | Novozymes Is Anything But Cheap | N/A | |
| 2021-04-28 05:29 EST | News | Novozymes A/S 2021 Q1 - Results - Earnings Call Presentation | N/A | |
| 2021-04-28 05:29 EST | News | Novozymes A/S (NVZMF) CEO Ester Baiget on Q1 2021 Results - Earnings Call Transcript | N/A | |
| 2021-03-18 23:30 EST | Analyst Rating | The Analyst Target Price has increased from $50.25 to $50.59. | Neutral | |
| 2021-03-17 22:35 EST | Analyst Rating | The Analyst Target Price has decreased from $50.44 to $50.25. | Sell | |
| 2021-03-17 14:38 EST | Analyst Rating | The Analyst Target Price has decreased from $50.45 to $50.44. | Sell | |
| 2021-03-16 22:54 EST | Analyst Rating | The Analyst Target Price has decreased from $50.58 to $50.45. | Sell | |
| 2021-03-13 05:06 EST | Analyst Rating | The Analyst Target Price has increased from $50.34 to $50.58. | Neutral | |
| 2021-03-12 13:06 EST | Analyst Rating | The Analyst Target Price has increased from $49.77 to $50.34. | Neutral | |
| 2021-03-12 05:23 EST | Analyst Rating | The Analyst Target Price has increased from $49.65 to $49.77. | Neutral | |
| 2021-03-12 05:03 EST | Dividend | A dividend of $0.85 has been announced on Nov 30, -0001. It will be paid Mar 31, 2021 with an ex-dividend date of Mar 12, 2021. | Neutral | |
| 2021-03-11 01:29 EST | Analyst Rating | The Analyst Target Price has increased from $49.45 to $49.65. | Neutral | |
| 2021-03-10 05:35 EST | Analyst Rating | The Analyst Target Price has decreased from $49.78 to $49.45. | Sell | |
| 2021-03-09 01:18 EST | Analyst Rating | The Analyst Target Price has decreased from $49.93 to $49.78. | Sell | |
| 2021-03-05 21:30 EST | Analyst Rating | The Analyst Target Price has increased from $49.85 to $49.93. | Neutral | |
| 2021-03-05 12:57 EST | Analyst Rating | The Analyst Target Price has decreased from $50.01 to $49.85. | Sell | |
| 2021-03-04 01:31 EST | Analyst Rating | The Analyst Target Price has increased from $49.86 to $50.01. | Neutral | |
| 2021-03-03 01:58 EST | Analyst Rating | The Analyst Target Price has decreased from $50.03 to $49.86. | Sell | |
| 2021-03-02 01:39 EST | Analyst Rating | The Analyst Target Price has decreased from $50.32 to $50.03. | Sell | |
| 2021-02-27 01:23 EST | Analyst Rating | The Analyst Target Price has decreased from $50.36 to $50.32. | Sell | |
| 2021-02-26 16:55 EST | Analyst Rating | The Analyst Target Price has decreased from $50.9 to $50.36. | Sell | |
| 2021-02-26 05:19 EST | Analyst Rating | The Analyst Target Price has increased from $50.83 to $50.9. | Neutral | |
| 2021-02-25 05:45 EST | Analyst Rating | The Analyst Target Price has decreased from $50.88 to $50.83. | Sell | |
| 2021-02-23 21:35 EST | Analyst Rating | The Analyst Target Price has increased from $50.72 to $50.88. | Neutral | |
About Novozymes A/S (NVZMY):
Novozymes A/S produces and sells industrial enzymes and microorganisms in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers agriculture solutions, including crop production, and animal health and nutrition solutions; liquefaction, saccharifaction, fermentation, cellulosic hydrolysis, and process enhancement solutions for bioenergy; baking, beverages, dairy, starch, and protein ingredients for the food and beverage industry; and laundry, dishwashing, and professional cleaning solutions for the household care industry. It also provides wastewater solutions, such as additives, biogas production, industrial bio cleaning, compound removal, odor control, and system start-up solutions; and textile solutions comprising denim abrasion and finishing, biopreparation, biopolishing bleach clean-up, and desizing solutions. In addition, the company offers forest products that include bleach boosting, deinking, fiber modification, effluent control, pitch and stickies control, and starch modification products; and leather solutions, which comprise biopreparation, degreasing, and re-bating. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis; and rTrypsin for cell culture. Novozymes A/S has collaboration with FMC Corporation to co-develop enzyme solutions. The company is based in Bagsvaerd, Denmark.
General
- Name Novozymes A/S
- Symbol NVZMY
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorBasic Materials
- IndustryChemicals
- Full Time Employees 5,903
- Last Split Factor5:1
- Last Split Date2011-12-09
- Fiscal Year EndDecember
- Web URLhttp://www.novozymes.com
View More
Valuation
- Trailing PE 33.79
- Forward PE 35.34
- Price/Sales (Trailing 12 Mt.) 7.98
- Price/Book (Most Recent Quarter) 9.84
- Enterprise Value Revenue 1.28
- Enterprise Value EBITDA 3.71
View More
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin 20%
- Return on Assets 11%
- Return on Equity 25%
- Earnings Per Share $1.69
- Revenue Per Share $0
- Gross Profit 7.85 billion
- Quarterly Earnings Growth -7.6%
View More
Highlights
- Market Capitalization 17.13 billion
- PEG Ratio 4.21
- Analyst Target Price $50.59
- Book Value Per Share $5.93
View More
Share Statistics
- Shares Outstanding 279.08 million
- Shares Float 206.54 million
- % Held by Insiders <1%
- % Held by Institutions 0.78%
View More
Technicals
- Beta 0.26
- 52 Week High $65.88
- 52 Week Low $40.11
- 50 Day Moving Average 62.64
- 200 Day Moving Average 60.78
View More
Dividends
- Forward Annual Dividend Rate $0.85
- Forward Annual Dividend Yield 1.34%
- Payout Ratio 57%
- Dividend Date 2021-03-31
- ExDividend Date 2021-03-12
- Dividend Per Share $0.85
- Dividend Yield 0%
View More
Novozymes A/S (NVZMY) Dividend Calendar:
NVZMY's last dividend payment was made to shareholders on March 31, 2021.
Novozymes A/S pays out 57% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|---|---|---|---|
| 2023-10-20 | 2023-11-01 | 2023-10-23 | 2023-10-12 | $0.59 |
| 2023-03-06 | 2023-03-23 | 2023-03-07 | 2023-01-30 | $0.88 |
| 2023-03-03 | 2023-03-22 | 2023-03-06 | 2023-01-30 | $0.88 |
| 2022-03-17 | 2022-04-05 | 2022-03-18 | 2022-02-04 | $0.85 |
| 2021-03-12 | 2021-03-31 | 2021-03-15 | 0000-00-00 | $0.85 |
| 2020-02-27 | 2020-03-17 | 2020-02-28 | 2020-01-24 | $0.78 |
| 2019-02-28 | 2019-03-19 | 2019-03-01 | 2019-02-07 | $0.76 |
| 2018-03-14 | 2018-04-02 | 2018-03-15 | 2018-03-20 | $0.74 |
| 2017-02-22 | 2017-03-14 | 2017-02-24 | 2017-01-19 | $0.57 |
| 2016-02-24 | 2016-03-15 | 2016-02-26 | 2016-01-21 | $0.51 |
| 2015-03-03 | 2015-03-17 | 2015-03-05 | 2015-02-23 | $0.45 |
Novozymes A/S (NVZMY) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-02 | $3.45 billion | $0.37 | ||
| 2020-09-30 | 2020-12-31 | $3.43 billion | $0.38 | ||
| 2020-06-30 | 2020-09-30 | $N/A | $0.40 | $2.33 | -82.9% |
| 2020-03-31 | 2020-06-30 | $N/A | $0.34 | $2.79 | -87.68% |
| 2019-12-31 | 2020-03-31 | $559.96 million | $0.43 | $2.82 | -84.91% |
| 2019-09-30 | 2019-12-31 | $540.75 million | $0.49 | $2.65 | -81.55% |
| 2019-06-30 | 2019-09-30 | $522.85 million | $0.33 | $3.42 | -90.48% |
| 2019-03-31 | 2019-06-30 | $522.87 million | $0.48 | ||
| 2018-12-31 | 2019-03-31 | $570.4 million | $0.36 | ||
| 2018-09-30 | 2018-10-24 | $568 million | $0.43 | ||
| 2018-06-30 | 2018-08-10 | $546.38 million | $0.42 | ||
| 2018-03-31 | 2018-04-25 | $581.31 million | $0.45 | ||
| 2017-12-31 | 2018-02-07 | $592.26 million | $2.69 | $2.90 | -7.24% |
| 2017-09-30 | 2017-10-25 | $564.33 million | $2.76 | $2.66 | 3.76% |
| 2017-06-30 | 2017-08-11 | $543.64 million | $2.47 | $2.57 | -3.89% |
| 2017-03-31 | 2017-04-26 | $3.74 billion | $2.58 | $2.51 | 2.79% |
| 2016-12-31 | 2017-01-18 | $3.71 billion | $0.39 | ||
| 2016-09-30 | 2016-10-26 | $2.48 | $2.63 | -5.7% | |
| 2016-06-30 | 2016-08-10 | $0.37 | |||
| 2016-03-31 | 2016-04-20 | $2.43 | $2.43 | 0% | |
| 2015-12-31 | 2016-01-19 | $2.27 | |||
| 2015-09-30 | 2015-10-22 | $2.40 | |||
| 2015-06-30 | 2015-08-06 | $1.34 | $2.40 | -44.17% | |
| 2015-03-31 | 2015-04-23 | $0.34 | |||
| 2014-12-31 | 2015-01-20 | $2.03 | |||
| 2014-09-30 | 2014-10-23 | $2.00 | $2.06 | -2.91% | |
| 2014-06-30 | 2014-08-14 | $1.87 | $1.94 | -3.61% | |
| 2014-03-31 | 2014-04-24 | $2.18 | $1.91 | 14.14% | |
| 2013-12-31 | 2014-01-21 | $1.77 | $1.71 | 3.51% | |
| 2013-09-30 | 2013-10-25 | $1.79 | $1.80 | -0.56% | |
| 2013-06-30 | 2013-08-09 | $0.31 | $0.34 | -8.82% | |
| 2013-03-31 | 2013-04-25 | $0.29 | |||
| 2012-12-31 | 2013-01-21 | $0.27 | |||
| 2012-09-30 | 2012-10-25 | $0.28 | $0.30 | -6.67% | |
| 2012-06-30 | 2012-08-16 | $0.27 | $0.27 | 0% | |
| 2012-03-31 | 2012-04-25 | $0.28 | $0.25 | 12% | |
| 2011-12-31 | 2012-01-19 | $0.20 | $0.22 | -9.09% | |
| 2011-09-30 | 2011-10-28 | $0.29 | $0.27 | 7.41% | |
| 2011-06-30 | 2011-08-11 | $0.27 | |||
| 2011-03-31 | 2011-04-29 | $0.28 | |||
| 2010-12-31 | 2011-01-21 | $0.20 | $0.17 | 16.29% | |
| 2010-09-30 | 2010-10-28 | $0.24 | $0.21 | 14.29% | |
| 2010-06-30 | 2010-08-12 | $0.22 | |||
| 2010-03-31 | 2010-04-29 | $0.24 | |||
| 2009-12-31 | 2010-01-21 | $0.19 | |||
| 2009-09-30 | 2009-10-28 | $0.19 | |||
| 2009-06-30 | 2009-08-13 | $0.16 | |||
| 2009-03-31 | 2009-04-29 | $0.17 | |||
| 2008-12-31 | 2009-01-22 | $0.14 | |||
| 2008-09-30 | 2008-10-31 | $0.17 | |||
| 2008-06-30 | 2008-08-14 | $0.19 | |||
| 2008-03-31 | 2008-04-24 | $0.17 | |||
| 2007-12-31 | 2008-01-25 | $0.14 | |||
| 2007-09-30 | 2007-10-25 | $0.14 | |||
| 2007-06-30 | 2007-08-09 | $0.18 | |||
| 2007-03-31 | 2007-04-25 | $0.14 | |||
| 2006-12-31 | 2007-01-25 | $0.13 | |||
| 2006-09-30 | 2006-10-25 | $0.12 | |||
| 2006-06-30 | 2006-08-08 | $0.13 | |||
| 2006-03-31 | 2006-04-26 | $0.10 | |||
| 2005-12-31 | 2006-01-24 | $0.09 | |||
| 2005-09-30 | 2005-10-27 | $0.11 |
Novozymes A/S (NVZMY) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Novozymes A/S (NVZMY) Chart:
Novozymes A/S (NVZMY) News:
Below you will find a list of latest news for Novozymes A/S (NVZMY) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Novozymes A/S (NVZMY) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Novozymes A/S (NVZMY) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2007-08-14 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1131345/000114420407042775/0001144204-07-042775-index.htm |
| 2010-03-16 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1131345/000119380510000721/0001193805-10-000721-index.htm |
| 2010-06-02 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1131345/000119380510001584/0001193805-10-001584-index.htm |
| 2017-09-29 | F-6 POS | Post-effective amendments for immediately effective filing | https://www.sec.gov/Archives/edgar/data/1131345/000119380517002625/0001193805-17-002625-index.htm |
| 2019-11-22 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1131345/000119380519001753/0001193805-19-001753-index.htm |
| 2005-10-25 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999705043717/9999999997-05-043717-index.htm |
| 2005-11-09 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999705045404/9999999997-05-045404-index.htm |
| 2005-10-18 | 12G32BR | Exemptions for American Depository Receipts and Certain Foreign Securities | https://www.sec.gov/Archives/edgar/data/1131345/999999999705045694/9999999997-05-045694-index.htm |
| 2005-10-18 | ARS | Annual Report to Security Holders | https://www.sec.gov/Archives/edgar/data/1131345/999999999705045696/9999999997-05-045696-index.htm |
| 2005-10-18 | ARS | Annual Report to Security Holders | https://www.sec.gov/Archives/edgar/data/1131345/999999999705045697/9999999997-05-045697-index.htm |
| 2005-12-01 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999705047808/9999999997-05-047808-index.htm |
| 2006-01-04 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706000359/9999999997-06-000359-index.htm |
| 2006-02-06 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706004526/9999999997-06-004526-index.htm |
| 2006-02-24 | ARS | Annual Report to Security Holders | https://www.sec.gov/Archives/edgar/data/1131345/999999999706006728/9999999997-06-006728-index.htm |
| 2006-03-06 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706007393/9999999997-06-007393-index.htm |
| 2006-03-13 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706008765/9999999997-06-008765-index.htm |
| 2006-05-08 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706018638/9999999997-06-018638-index.htm |
| 2006-05-18 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706020519/9999999997-06-020519-index.htm |
| 2006-06-21 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706026238/9999999997-06-026238-index.htm |
| 2006-07-31 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706032473/9999999997-06-032473-index.htm |
| 2006-08-18 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706035816/9999999997-06-035816-index.htm |
| 2006-08-22 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706035993/9999999997-06-035993-index.htm |
| 2006-09-05 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706037333/9999999997-06-037333-index.htm |
| 2006-09-05 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706037411/9999999997-06-037411-index.htm |
| 2006-11-07 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706045073/9999999997-06-045073-index.htm |
| 2006-12-07 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706048485/9999999997-06-048485-index.htm |
| 2006-12-21 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999706049730/9999999997-06-049730-index.htm |
| 2007-02-06 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999707005493/9999999997-07-005493-index.htm |
| 2007-02-20 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999707006589/9999999997-07-006589-index.htm |
| 2007-02-27 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999707007788/9999999997-07-007788-index.htm |
| 2007-02-27 | ARS | Annual Report to Security Holders | https://www.sec.gov/Archives/edgar/data/1131345/999999999707007927/9999999997-07-007927-index.htm |
| 2007-03-15 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999707011876/9999999997-07-011876-index.htm |
| 2007-04-18 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999707019518/9999999997-07-019518-index.htm |
| 2007-04-23 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999707020129/9999999997-07-020129-index.htm |
| 2007-05-02 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999707022154/9999999997-07-022154-index.htm |
| 2007-06-14 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999707028299/9999999997-07-028299-index.htm |
| 2007-06-25 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999707029702/9999999997-07-029702-index.htm |
| 2008-02-13 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1131345/999999999708006211/9999999997-08-006211-index.htm |
| 2008-02-25 | ARS | Annual Report to Security Holders | https://www.sec.gov/Archives/edgar/data/1131345/999999999708007733/9999999997-08-007733-index.htm |
| 2009-02-24 | ARS | Annual Report to Security Holders | https://www.sec.gov/Archives/edgar/data/1131345/999999999709004778/9999999997-09-004778-index.htm |